Rising preference for minimally invasive surgical procedures, increasing investments in research and development activities to develop advanced surgical devices, and rising number of product approvals are some key factors expected to drive global market growth.
Rising preference for minimally invasive surgical procedures, increasing investments in research and development activities to develop advanced surgical devices, and rising number of product approvals are some key factors expected to drive global market growth
According to Emergen Research, the global embolotherapy market size was USD 3.50 billion in 2020 and is expected to reach USD 7.13 billion in 2028 and register a steady revenue CAGR of 9.3% during the forecast period, 2021-2028.
Market Dynamics:
Embolotherapy is a minimally invasive technique used for arresting hemorrhage in various clinical conditions such as malignancy, hemobilia, pancreatitis, and ulcerative disease. It also aids in reducing tumors. Embolotherapy has emerged as an effective alternative to invasive surgeries. Over recent years, there has been a rapid increase in the adoption of embolotherapy by interventional radiologists for various clinical conditions including liver cancer, neurological diseases, peripheral artery disease, and uterine fibroids among others. It is also used in treating resistant painful conditions such as frozen shoulders and osteoporosis.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/763
Factors such as increasing number of minimally invasive procedures performed across the globe, rapid technological advancements in embolotherapy, rising investments and grants by public and private sectors, and availability of advanced embolotherapy devices at cost-effective prices are expected to drive global market revenue growth during the forecast period. In addition, growing geriatric population, increasing applications of embolotherapy devices, rising disposable income among individuals in developing countries, and increasing investments to develop improved products are key factors expected to fuel global market growth during the forecast period. However, lack of skilled professionals, growing inclination toward effective alternatives such as chemotherapy, radiation therapy, or surgery for treating various conditions, and unawareness about embolotherapy are some key factors that can hamper global market growth to a certain extent going ahead.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Embolic Agents Segment to Account for Largest Revenue Share:
The embolic agents segment is expected to account for largest revenue share during the forecast period owing to increasing number of interventional radiology procedures and rising need for advanced embolic agents such as microspheres and liquid embolic agents. Other factors such as availability of effective embolic agents and growing investments to develop more enhanced products are some other key factors expected to drive revenue growth of the segment.
Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/763
Ambulatory Surgical Centers Segment Register Rapid Revenue CAGR:
The ambulatory surgical centers segment is expected to register rapid revenue CAGR over the forecast period owing to increasing inclination towards outpatient surgical care, rapid adoption of advanced surgical equipment, and rising demand for minimally invasive procedures.
North America To Lead In Terms of Revenue Share:
North America is expected to dominate other regional markets in terms of revenue share over the forecast period owing to rising prevalence of chronic diseases such as neurological disorders, cancer, peripheral artery disease, rapid advancements in embolotherapy, and increasing public awareness. In addition, increasing demand for minimally invasive surgeries, presence of well-established healthcare facilities, high focus on developing advanced embolic agents, and rising investments in R&D activities are other factors expected to drive North America market growth.
Major Companies in the Market Include:
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic PLC
- Terumo Medical Corporation
- Penumbra Inc.
- Johnson & Johnson
- Merit Medical Systems Inc.,
- Cook Medical Inc.
- Kaneka Corporation
- Stryker Corporation
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/embolotherapy-market
For the purpose of this report, Emergen Research has segmented the global embolotherapy market on the basis of product, procedure, application, end-use, and region:
Product Outlook (Revenue, USD Billion; 2018–2028)
- Embolic Agents
- Liquid Embolic Agents
- Microspheres
- Embolization Coils
- Detachable Coils
- Pushable Coils
- Detachable Balloons
- Embolic Plug Systems
- Support Devices
- Microcatheters
- Guidewires
Procedure Outlook (Revenue, USD Billion; 2018–2028)
- Transcatheter Arterial Embolization
- Transcatheter Arterial Radioembolization
- Transcatheter Chemoembolization
Application Outlook (Revenue, USD Billion; 2018–2028)
- Cancer
- Peripheral Vascular Disease
- Neurological Disease
- Urological & Nephrological Disorders
- Others
End Use Outlook (Revenue, USD Billion; 2018–2028)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Latest Reports Published by Emergen Research:
Mobile App Development Platforms Market By Deployment (Cloud, On-premises), By Organization Size (Large Enterprises, Small & Medium-sized Businesses), By Operating System (Android, iOS, Others), By End-Use (Healthcare, BFSI, Retail, and Others), and By Region Forecast to 2028.
Metaverse in Media and Entertainment Market, By Technology (Blockchain, AI, AR, VR, XR, MR, IoT), By Product (Cryptocurrency, NFTs, Digital Assets, Others), By End-Use (Film Production Companies, Music Labels, OTT Platforms, Television Broadcasters, Artists, Others), and By Region Forecast to 2030.
Cloud Database Security Market Size, Share, Trends, By Type (Public Cloud, Private Cloud, Hybrid Cloud), By Application (Cloud Activity Monitoring, User Authentication, Others), By Industry Vertical, and By Region Forecast to 2028.
Metaverse in Education Market by Technology (AR, VR, XR, MR), By Device (VR Headset, AR Glasses), By Application (Learning, Skill Development, Educational Apps, Self-Regulation Skills, Cultural Understanding, Others), and By Region Forecast to 2030.
Neurological Game Technology Market, By Component (Hardware, Software), By Technology (Brain-Computer Interface, Augmented Reality (AR) Technology, Virtual Reality (VR) Technology, Haptic Technology), By End-Use and By Region Forecast to 2030.
Hadoop Big Data Analytics Market, By Component (Solution, Services), By Deployment (On-premises, Cloud), By Application (Customer Analytics, Risk and Fraud Analytics, Security Intelligence, Internet of Things (IoT), Supply Chain Analytics, Others), By End-Use, and By Region Forecast to 2028.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Our Press release@ https://www.emergenresearch.com/press-release/global-embolotherapy-market